TOWA Pharmaceutical Co (TSE:4553) Total Liabilities : 円265,867 Mil (As of Dec. 2023)

View and export this data going back to 2004. Start your Free Trial

What is TOWA Pharmaceutical Co Total Liabilities?

TOWA Pharmaceutical Co's Total Liabilities for the quarter that ended in Dec. 2023 was 円265,867 Mil.

TOWA Pharmaceutical Co's quarterly Total Liabilities declined from Jun. 2023 (円250,175.00 Mil) to Sep. 2023 (円246,059.00 Mil) but then increased from Sep. 2023 (円246,059.00 Mil) to Dec. 2023 (円265,867.00 Mil).

TOWA Pharmaceutical Co's annual Total Liabilities increased from Mar. 2022 (円199,929.00 Mil) to Mar. 2023 (円234,454.00 Mil) and increased from Mar. 2023 (円234,454.00 Mil) to Mar. 2024 (円274,762.00 Mil).

TOWA Pharmaceutical Co Total Liabilities Historical Data

The historical data trend for TOWA Pharmaceutical Co's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

TOWA Pharmaceutical Co Total Liabilities Chart

TOWA Pharmaceutical Co Annual Data

Trend

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Total Liabilities

Get a 7-Day Free Trial

125,353.00

129,070.00

199,929.00

234,454.00

274,762.00

TOWA Pharmaceutical Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Total Liabilities	Get a 7-Day Free Trial															234,454.00	250,175.00	246,059.00	265,867.00	274,762.00

TOWA Pharmaceutical Co Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

TOWA Pharmaceutical Co's Total Liabilities for the fiscal year that ended in Mar. 2024 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	80118	+	(189124	+	5300
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0	+	220)
	=	274,762

Total Liabilities	=	Total Assets (A: Mar. 2024 )	-	Total Equity (A: Mar. 2024 )
	=	430653	-	155891
	=	274,762

TOWA Pharmaceutical Co's Total Liabilities for the quarter that ended in Dec. 2023 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	76955	+	(183611	+	5061
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0	+	240)
	=	265,867

Total Liabilities	=	Total Assets (Q: Dec. 2023 )	-	Total Equity (Q: Dec. 2023 )
	=	414685	-	148818
	=	265,867

TOWA Pharmaceutical Co Total Liabilities Related Terms

Thank you for viewing the detailed overview of TOWA Pharmaceutical Co's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

TOWA Pharmaceutical Co (TSE:4553) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » TOWA Pharmaceutical Co Ltd (TSE:4553) » Definitions » Total Liabilities

Comparable Companies

Traded in Other Exchanges

6QC:Germany

Address

2-11, Shinbashi-cho, Kadoma, Osaka, JPN, 571-8580

Website

http://www.towayakuhin.co.jp

TOWA Pharmaceutical Co Ltd is a Japan based pharmaceutical company engaged in research and development, production, and marketing of generic drugs. It also provides drug consulting services for patients and their families and relatives. It organizes academic seminars for medical professionals and posts articles in journals. It participates in training for pharmacists. The company has three main plants in operation namely Osaka plant, Okayama plant, and Yamagata plant. Towa has offers more than 500 drugs to meet the diverse therapeutic requirements including lifestyle related diseases such as hypertension and diabetes, digestive system diseases, nervous system diseases and allergic diseases, vitamins and antibiotics.

TOWA Pharmaceutical Co (TSE:4553) Headlines

No Headlines